Cardiac Imaging

Why Start With Chest Radiography for Repaired Tetralogy of Fallot Follow-Up?

A 34-year-old patient with a history of Tetralogy of Fallot, repaired in childhood, presents to your clinic with progressive exertional dyspnea. His recent transthoracic echocardiogram (TTE) was technically limited due to poor acoustic windows, providing an incomplete assessment of his right ventricular outflow tract and pulmonary valve. You are now faced with a critical decision: what is the appropriate next imaging study to evaluate for suspected pulmonary valve dysfunction or branch pulmonary artery stenosis? This article provides a detailed clinical workflow for this specific scenario, guiding you through the differential diagnosis, study rationale, and downstream decision-making. While advanced modalities are often the ultimate destination, the American College of Radiology (ACR) rates Chest Radiography as Usually Appropriate, serving as a crucial, low-risk initial step in the diagnostic pathway.

Who Fits This Clinical Scenario?

This guidance applies to a specific patient population: children or adults with a history of surgically repaired Tetralogy of Fallot (TOF) or congenital pulmonary valve stenosis. The central clinical question is a concern for long-term sequelae, namely pulmonary valve dysfunction (most commonly regurgitation) or stenosis of the branch pulmonary arteries. A critical inclusion criterion is that a prior TTE has already been performed but was deemed incomplete, inadequate, or technically limited, failing to provide the necessary diagnostic information about cardiovascular morphology and function.

This workflow is distinct from the evaluation of other complex congenital heart diseases. It does not apply to patients with:

  • Transposition of the Great Arteries (TGA): Patients with a history of an atrial switch (Mustard or Senning) or an arterial switch procedure have different long-term complications and follow a separate diagnostic algorithm.
  • Single Ventricle Physiology: Patients who have undergone staged palliation (e.g., Glenn or Fontan procedures) require a unique imaging approach tailored to their specific surgical stage and physiology.
  • Acute, Decompensated Symptoms: In a patient presenting with acute heart failure, syncope, or significant arrhythmia, the clinical urgency may warrant proceeding directly to more definitive imaging like Cardiac MRI or CT, bypassing preliminary studies.

This focused approach ensures the right imaging test is selected for the right patient, avoiding unnecessary radiation and diagnostic delays.

What Diagnoses Are You Working Up in This Scenario?

When TTE is inconclusive in a patient with repaired TOF, your imaging choice is guided by a well-defined differential diagnosis focused on the known long-term complications of the initial repair. The goal is to identify anatomical and functional issues before they lead to irreversible ventricular dysfunction.

Significant Pulmonary Regurgitation (PR): This is the most common and anticipated long-term consequence following TOF repair, particularly after a transannular patch. Chronic, severe PR imposes a volume load on the right ventricle (RV), leading to progressive dilation, dysfunction, increased risk of arrhythmias, and eventual heart failure. Quantifying the severity of PR is a primary goal of follow-up imaging.

Right Ventricular Dilation and Dysfunction: As a direct result of chronic volume or pressure overload, the RV can dilate and its systolic function can decline. Imaging is used to measure RV volumes, mass, and ejection fraction. These metrics are critical for determining the optimal timing for pulmonary valve replacement.

Residual or Recurrent Right Ventricular Outflow Tract (RVOT) Obstruction: While the initial repair addresses RVOT obstruction, stenosis can recur at the valvular, subvalvular, or supravalvular levels. This pressure load on the RV can cause hypertrophy and dysfunction, contributing to symptoms and adverse outcomes.

Branch Pulmonary Artery Stenosis: Stenosis of the right or left pulmonary arteries is another key concern. It may be a residual lesion from the patient’s native anatomy or a complication of prior surgical shunts or patches. Significant stenosis can create a substantial pressure load on the RV and lead to unequal blood flow to the lungs.

Aortic Root and Ascending Aorta Dilation: Patients with TOF have an intrinsic predisposition to aortic dilation, which can progress over their lifetime. Monitoring aortic size is an important, albeit secondary, component of the comprehensive assessment.

Why Is a Chest Radiograph a ‘Usually Appropriate’ First Step?

While Cardiac Magnetic Resonance Imaging (CMR) is the gold standard for functional assessment in this population, the ACR designates a simple chest radiograph as Usually Appropriate. This recommendation positions the radiograph as a valuable, low-risk, and widely available initial examination that can provide important contextual information before proceeding to more complex and costly imaging.

The primary rationale for starting with a chest radiograph is its ability to provide a global assessment of cardiopulmonary status with minimal radiation exposure. For an adult, the typical radiation dose is less than 0.1 mSv (ACR RRL ☢), and for a child, it is less than 0.03 mSv (ACR RRL ☢). This is orders of magnitude lower than a CT scan. A radiograph can reveal:

  • Cardiomegaly: An increased cardiothoracic ratio can suggest significant right-sided chamber enlargement secondary to chronic pulmonary regurgitation.
  • Pulmonary Artery Segment Changes: A prominent main pulmonary artery segment may indicate post-stenotic dilation or effects from chronic volume overload.
  • Pulmonary Vasculature: The pattern of pulmonary vascular markings can provide clues about shunt physiology or pulmonary hypertension.
  • Surgical Hardware: The position of sternal wires, clips, and conduits can be assessed.
  • Extracardiac Findings: A radiograph can identify alternative causes of symptoms, such as pneumonia or other lung parenchymal disease.

It is crucial to understand the limitations of a chest radiograph. It cannot quantify ventricular volumes, measure ejection fraction, or directly visualize and measure the severity of valve regurgitation or arterial stenosis. Therefore, it is not the definitive study in this scenario.

Other advanced imaging modalities are also rated Usually Appropriate, and one will almost certainly be required after the radiograph.

  • MRI of the heart for function and morphology is the definitive non-invasive test. It provides precise, reproducible measurements of RV and left ventricular (LV) volumes, function, and mass, and allows for direct quantification of the pulmonary regurgitant fraction. It is performed without ionizing radiation (ACR RRL O).
  • CTA of the chest with IV contrast offers excellent spatial resolution for delineating the anatomy of the RVOT, pulmonary arteries, aorta, and coronary arteries, but involves significant ionizing radiation (ACR RRL ☢☢☢ to ☢☢☢☢) and iodinated contrast.

The chest radiograph serves as a foundational baseline, complementing the more detailed functional and anatomical data that will be obtained from a subsequent CMR or CT.

What’s Next After a Chest Radiograph? Downstream Workflow

The chest radiograph is a starting point, not an endpoint. The results, whether positive or negative, guide the next step in the workup, which almost invariably involves advanced cross-sectional imaging given the initial inadequate echocardiogram.

  • If the radiograph shows significant cardiomegaly or a prominent main pulmonary artery: These findings increase the clinical suspicion for severe pulmonary regurgitation and significant RV dilation. This result strongly supports proceeding directly to Cardiac MRI. The MRI will be used to quantify RV volumes and the regurgitant fraction, providing the objective data needed to guide discussions about the timing of potential pulmonary valve replacement.
  • If the radiograph is normal or shows only non-specific postoperative changes: A normal chest radiograph does not rule out hemodynamically significant pathology. Because the TTE was inadequate and clinical concern persists, the next step remains advanced imaging. Cardiac MRI is still the preferred modality to definitively assess RV function and quantify PR, which can be severe even with a normal cardiac silhouette.
  • If the radiograph reveals unexpected findings: Should the image show evidence of lung parenchymal disease, pleural effusions, or other abnormalities, the differential diagnosis for the patient’s dyspnea may need to be broadened. While a cardiac workup will likely still be necessary, these findings may trigger a parallel pulmonary evaluation.

In essence, for a patient with repaired TOF and an inadequate TTE, the clinical pathway leads to Cardiac MRI. The initial chest radiograph serves to either reinforce the need for MRI or, in rare cases, introduce an alternative diagnosis for the patient’s symptoms.

Pitfalls to Avoid (and When to Get Help)

Navigating the long-term follow-up of patients with repaired congenital heart disease requires careful attention to detail. Here are several common pitfalls to avoid in this specific scenario:

  • Stopping the Workup: The most significant error is accepting a normal or non-specific chest radiograph as a reason to halt the investigation. When TTE is inadequate, a normal radiograph is falsely reassuring and does not exclude severe PR or RV dysfunction.
  • Ignoring Serial Changes: A single chest radiograph is less valuable than a comparison to prior studies. Subtle increases in cardiac size over time can be an early indicator of worsening RV volume overload.
  • Forgetting the Aorta: While clinical concern is focused on the right heart and pulmonary arteries, remember to evaluate the aortic shadow on the radiograph. Progressive aortic root dilation is a known long-term risk in the TOF population.
  • Delaying Advanced Imaging in Symptomatic Patients: While a radiograph is a reasonable first step in a stable patient, any acute worsening of symptoms, new arrhythmia, or signs of heart failure should prompt an escalation. If a patient presents with syncope, chest pain, or severe decompensation, consult cardiology immediately and proceed directly to the most appropriate definitive imaging study, typically CMR or CT.

Related ACR Topics and Tools

The American College of Radiology provides a comprehensive set of guidelines for various clinical presentations. For breadth across all scenarios in Congenital or Acquired Heart Disease, see our parent guide: Congenital or Acquired Heart Disease: ACR Appropriateness Decoded.

For additional decision support and technical details, the following GigHz tools are available:

Frequently Asked Questions

Why is Cardiac MRI also ‘Usually Appropriate’? When should I choose it over a chest radiograph?

Cardiac MRI (CMR) is considered the gold standard for quantifying right ventricular size, function, and the amount of pulmonary regurgitation. While a chest radiograph is a simple, low-radiation first step, CMR is the definitive problem-solving study in this scenario. After an inadequate TTE, you will almost always proceed to CMR to get the quantitative data needed for clinical management, such as timing for pulmonary valve replacement. The chest radiograph is a preliminary step, while CMR is the destination.

What if my patient has a pacemaker or defibrillator and cannot undergo an MRI?

This is a critical consideration. If a patient has a non-MRI-conditional device or other contraindication to MRI, the next best imaging modality is a CT heart function and morphology with IV contrast or a CTA chest with IV contrast. Both are rated ‘Usually Appropriate’ by the ACR. CT provides excellent anatomical detail of the RVOT, pulmonary arteries, and aorta, and with ECG-gating, can provide reasonable estimates of ventricular function, though it is less accurate than MRI for this purpose and involves ionizing radiation.

Is a transesophageal echocardiogram (TEE) a good alternative?

A TEE is rated as ‘May be appropriate’ by the ACR for this scenario. While TEE can provide better visualization of cardiac structures than a TTE, it is often still limited in its views of the RVOT and main pulmonary artery. Furthermore, it is an invasive procedure requiring sedation. Given the superiority of non-invasive CMR and CT for comprehensively evaluating the right heart and great vessels, TEE is typically reserved for specific situations where other imaging is contraindicated or has also been inconclusive.

Does this guidance apply to patients who have not had surgery for Tetralogy of Fallot?

No, this specific workflow is for patients with repaired Tetralogy of Fallot or pulmonary stenosis. The imaging workup for an unrepaired patient would be different, focusing on defining the primary anatomy for initial surgical planning rather than evaluating for long-term postoperative complications.

How often should patients with repaired TOF get follow-up imaging?

The frequency of imaging depends on the individual patient’s clinical status, the severity of their pulmonary regurgitation, and their RV size and function. Asymptomatic patients with mild to moderate PR and normal RV size may undergo surveillance TTE every 1-2 years. Patients with severe PR or RV dilation require more frequent monitoring, often with serial Cardiac MRIs every 1-3 years, as determined by a cardiologist specializing in adult congenital heart disease.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026